Tele: 561.316.3330

Breaking Medical Device Industry News

Friday, October 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEnvisagenics
HomeEnvisagenics

Envisagenics

Envisagenics Announces Research Program with the Lung Cancer Initiative at Johnson & Johnson

Through this initiative, Envisagenics will build predictive models for lung cancer progression and risk. The Envisagenics team will leverage its expertise in splicing and RNA-sequencing to analyze LCI's data using Envisagenics' SpliceCore® software platform.

By using this website you agree to accept Medical Device News Magazine Privacy Policy